SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?


To: ~digs who wrote (471)5/3/2004 5:20:28 PM
From: ~digs  Read Replies (1) | Respond to of 7944
 
HMSL @ .70 -9%

gap closure on daily chart stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!Ul14!Uk14]&pref=G

Hemosol is a biopharmaceutical company focused on the development and manufacturing of biologics, particularly blood-related proteins. The Company has a broad range of novel therapeutic products in development, including HEMOLINK(TM) (hemoglobin reaffimer), an oxygen therapeutic designed to rapidly and safely improve oxygen delivery via the circulatory system.

Hemosol Announces Closing of Reorganization and Cash Infusion ; Monday May 3, 7:31 am ET biz.yahoo.com